Since taking over at ImClone, he's installed one director from his own firm and two others that may be friendly to him, including a Harvard Medical School professor Icahn also nominated for the board of Biogen Idec when he sought to take control there.

FORBES: BristolClone? Watch Wilmington.

Since taking over at ImClone, he's installed one director from his own firm and two others that may be friendly to him, including a Harvard Medical School professor Icahn also nominated for the board of Biogen Idec (nasdaq: BIIB - news - people ) when he sought to take control there.

FORBES: BristolClone? Watch Wilmington.

We are learning from ourselves and are open to hearing friendly advice from others but what we do not need is to be lectured.

FORBES: Dmitry Medvedev's Davos Keynote: Complete Transcript